Guido Zaman and Suzanne van Gerwen will attend the Discovery on Target conference, that will be held in Boston (USA) from September 21st to 24th.

On Thursday September 24th at 12.10 p.m., Guido Zaman will present a lecture in the Kinase Inhibitor track, entitled:

Selective TTK inhibitors with long target residence time and potent anti-tumor activity

The presentation will cover NTRC’s drug discovery program on TTK inhibitors and provide case-studies of ResidenceTimer™, Oncolines™ and SynergyFinder™.

Hope to see you in Boston!

Link to conference website.